SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-23-001820
Filing Date
2023-01-19
Accepted
2023-01-19 08:15:34
Documents
15
Period of Report
2023-01-19
Items
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 45402
2 ex99-1.htm EX-99.1 23857
3 GRAPHIC ex99-1_01.jpg GRAPHIC 31879
4 GRAPHIC ex99-1_02.jpg GRAPHIC 47024
  Complete submission text file 0001493152-23-001820.txt   365309

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE sonn-20230119.xsd EX-101.SCH 3230
6 XBRL LABEL FILE sonn-20230119_lab.xml EX-101.LAB 34916
7 XBRL PRESENTATION FILE sonn-20230119_pre.xml EX-101.PRE 22791
9 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3790
Mailing Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540
Business Address 100 OVERLOOK CENTER SUITE 102 PRINCETON NJ 08540 609-375-2227
Sonnet BioTherapeutics Holdings, Inc. (Filer) CIK: 0001106838 (see all company filings)

IRS No.: 522102141 | State of Incorp.: DE | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-35570 | Film No.: 23535969
SIC: 2834 Pharmaceutical Preparations